IBDEI36K ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,50781,1,4,0)
 ;;=4^C78.00
 ;;^UTILITY(U,$J,358.3,50781,2)
 ;;=^5001334
 ;;^UTILITY(U,$J,358.3,50782,0)
 ;;=D57.1^^193^2497^187
 ;;^UTILITY(U,$J,358.3,50782,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50782,1,3,0)
 ;;=3^Sickle-Cell Disease w/o Crisis
 ;;^UTILITY(U,$J,358.3,50782,1,4,0)
 ;;=4^D57.1
 ;;^UTILITY(U,$J,358.3,50782,2)
 ;;=^5002309
 ;;^UTILITY(U,$J,358.3,50783,0)
 ;;=D75.1^^193^2497^185
 ;;^UTILITY(U,$J,358.3,50783,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50783,1,3,0)
 ;;=3^Polycythemia,Secondary
 ;;^UTILITY(U,$J,358.3,50783,1,4,0)
 ;;=4^D75.1
 ;;^UTILITY(U,$J,358.3,50783,2)
 ;;=^186856
 ;;^UTILITY(U,$J,358.3,50784,0)
 ;;=C90.30^^193^2497^188
 ;;^UTILITY(U,$J,358.3,50784,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50784,1,3,0)
 ;;=3^Solitary Plasmacytoma,Not in Remission
 ;;^UTILITY(U,$J,358.3,50784,1,4,0)
 ;;=4^C90.30
 ;;^UTILITY(U,$J,358.3,50784,2)
 ;;=^5001759
 ;;^UTILITY(U,$J,358.3,50785,0)
 ;;=D56.3^^193^2497^189
 ;;^UTILITY(U,$J,358.3,50785,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50785,1,3,0)
 ;;=3^Thalassemia Minor
 ;;^UTILITY(U,$J,358.3,50785,1,4,0)
 ;;=4^D56.3
 ;;^UTILITY(U,$J,358.3,50785,2)
 ;;=^340497
 ;;^UTILITY(U,$J,358.3,50786,0)
 ;;=D56.9^^193^2497^190
 ;;^UTILITY(U,$J,358.3,50786,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50786,1,3,0)
 ;;=3^Thalassemia,Unspec
 ;;^UTILITY(U,$J,358.3,50786,1,4,0)
 ;;=4^D56.9
 ;;^UTILITY(U,$J,358.3,50786,2)
 ;;=^340606
 ;;^UTILITY(U,$J,358.3,50787,0)
 ;;=M31.1^^193^2497^192
 ;;^UTILITY(U,$J,358.3,50787,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50787,1,3,0)
 ;;=3^Thrombotic Microangiopathy
 ;;^UTILITY(U,$J,358.3,50787,1,4,0)
 ;;=4^M31.1
 ;;^UTILITY(U,$J,358.3,50787,2)
 ;;=^119061
 ;;^UTILITY(U,$J,358.3,50788,0)
 ;;=D51.2^^193^2497^193
 ;;^UTILITY(U,$J,358.3,50788,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50788,1,3,0)
 ;;=3^Transcobalamin II Deficiency
 ;;^UTILITY(U,$J,358.3,50788,1,4,0)
 ;;=4^D51.2
 ;;^UTILITY(U,$J,358.3,50788,2)
 ;;=^5002286
 ;;^UTILITY(U,$J,358.3,50789,0)
 ;;=D05.92^^193^2497^36
 ;;^UTILITY(U,$J,358.3,50789,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50789,1,3,0)
 ;;=3^Carcinoma in Situ Left Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,50789,1,4,0)
 ;;=4^D05.92
 ;;^UTILITY(U,$J,358.3,50789,2)
 ;;=^5001937
 ;;^UTILITY(U,$J,358.3,50790,0)
 ;;=D05.91^^193^2497^38
 ;;^UTILITY(U,$J,358.3,50790,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50790,1,3,0)
 ;;=3^Carcinoma in Situ Right Breast,Unspec Type
 ;;^UTILITY(U,$J,358.3,50790,1,4,0)
 ;;=4^D05.91
 ;;^UTILITY(U,$J,358.3,50790,2)
 ;;=^5001936
 ;;^UTILITY(U,$J,358.3,50791,0)
 ;;=D05.90^^193^2497^34
 ;;^UTILITY(U,$J,358.3,50791,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50791,1,3,0)
 ;;=3^Carcinoma in Situ Breast Unspec,Unspec Type
 ;;^UTILITY(U,$J,358.3,50791,1,4,0)
 ;;=4^D05.90
 ;;^UTILITY(U,$J,358.3,50791,2)
 ;;=^5001935
 ;;^UTILITY(U,$J,358.3,50792,0)
 ;;=D51.0^^193^2497^194
 ;;^UTILITY(U,$J,358.3,50792,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50792,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Intrinsic Factor Deficiency
 ;;^UTILITY(U,$J,358.3,50792,1,4,0)
 ;;=4^D51.0
 ;;^UTILITY(U,$J,358.3,50792,2)
 ;;=^5002284
 ;;^UTILITY(U,$J,358.3,50793,0)
 ;;=D51.1^^193^2497^195
 ;;^UTILITY(U,$J,358.3,50793,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,50793,1,3,0)
 ;;=3^Vitamin B12 Deficiency Anemia d/t Selective Vit B12 Malabsorp w/ Proteinuria
